Filing Details
- Accession Number:
- 0001127602-12-010611
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-13 20:23:39
- Reporting Period:
- 2011-03-14
- Filing Date:
- 2012-03-13
- Accepted Time:
- 2012-03-13 20:23:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1016369 | D Leonard Schaeffer | 2525 Dupont Drive Irvine CA 92612 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-03-14 | 4,250 | $71.50 | 9,050 | No | 4 | P | Direct | |
Common Stock | Disposition | 2011-05-12 | 213 | $81.09 | 4,037 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-05-13 | 221 | $81.58 | 3,816 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-05-16 | 91 | $81.59 | 3,725 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-09-13 | 222 | $82.01 | 3,503 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 56,066 | Indirect | By Family Trust |
Footnotes
- Purchase of stock in the open market.
- Sale of stock in the open market. The reporting person has paid to the issuer all short swing profits under Section 16(b) of the Securities Exchange Act realized on the reported transactions. The transactions were conducted in a discretionary brokerage account without the reporting person's prior knowledge or approval. The sales transactions were conducted subsequent to the reporting person's retirement as a director of the issuer.
- The price reported in column 4 is the weighted average price. These shares were sold in multiple transaction at prices ranging from $81.06 to $81.21.
- The balance reflects the transfer on May 11, 2011, of 4,800 shares held directly by the reporting person to the Schaeffer Revocable Family Trust dated 10/2/97 established by reporting person as co-settler for the benefit of self and others (the "Family Trust").
- Shares held by the Family Trust.